LYNX-3, the second pivotal Phase 3 trial in keratorefractive participants with visual disturbances under mesopic, low-contrast conditions, is ongoing with topline results expected in the first half of ...
Coordinated eye-body movements are essential for adaptive behavior, yet little is known about how multisensory input, particularly chemosensory cues, shapes this coordination. Using our enhanced ...